United States Systemic Lupus Erythematous SLE Drugs Market Report 2017

January 2017 | 121 pages | ID: U1C149904B2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Systemic Lupus Erythematous SLE Drugs

Revenue, means the sales value of Systemic Lupus Erythematous SLE Drugs

This report studies sales (consumption) of Systemic Lupus Erythematous SLE Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Anthera Pharmaceuticals BMS
• GSK
• ImmuPharma
• Merck Serono
• UCB
• Amgen
• HGS
• Immunomedics
• MedImmune
• Sanofi

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Corticosteroids
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Anti-Inflammatories
• Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
• Antimalarials
• BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS)
• Immunosuppressive Agents/Immune Modulators
• Anticoagulants

Split by applications, this report focuses on sales, market share and growth rate of Systemic Lupus Erythematous SLE Drugs in each application, can be divided into

• Hospitals
• Hospital Pharmacies
• Drug Stores
• Online Drug Stores

Contents

United States Systemic Lupus Erythematous SLE Drugs Market Report 2017

1 SYSTEMIC LUPUS ERYTHEMATOUS SLE DRUGS OVERVIEW

1.1 Product Overview and Scope of Systemic Lupus Erythematous SLE Drugs
1.2 Classification of Systemic Lupus Erythematous SLE Drugs
  1.2.1 Corticosteroids
  1.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  1.2.3 Anti-Inflammatories
  1.2.4 Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
  1.2.5 Antimalarials
  1.2.6 BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS)
  1.2.7 Immunosuppressive Agents/Immune Modulators
  1.2.8 Anticoagulants
1.3 Application of Systemic Lupus Erythematous SLE Drugs
  1.3.1 Hospitals
  1.3.2 Hospital Pharmacies
  1.3.3 Drug Stores
  1.3.4 Online Drug Stores
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Systemic Lupus Erythematous SLE Drugs (2012-2022)
  1.4.1 United States Systemic Lupus Erythematous SLE Drugs Sales and Growth Rate (2012-2022)
  1.4.2 United States Systemic Lupus Erythematous SLE Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES SYSTEMIC LUPUS ERYTHEMATOUS SLE DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Systemic Lupus Erythematous SLE Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Systemic Lupus Erythematous SLE Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Systemic Lupus Erythematous SLE Drugs Average Price by Manufactures (2015 and 2016)
2.4 Systemic Lupus Erythematous SLE Drugs Market Competitive Situation and Trends
  2.4.1 Systemic Lupus Erythematous SLE Drugs Market Concentration Rate
  2.4.2 Systemic Lupus Erythematous SLE Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES SYSTEMIC LUPUS ERYTHEMATOUS SLE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Systemic Lupus Erythematous SLE Drugs Sales and Market Share by States (2012-2017)
3.2 United States Systemic Lupus Erythematous SLE Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Systemic Lupus Erythematous SLE Drugs Price by States (2012-2017)

4 UNITED STATES SYSTEMIC LUPUS ERYTHEMATOUS SLE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Systemic Lupus Erythematous SLE Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Systemic Lupus Erythematous SLE Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Systemic Lupus Erythematous SLE Drugs Price by Type (2012-2017)
4.4 United States Systemic Lupus Erythematous SLE Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SYSTEMIC LUPUS ERYTHEMATOUS SLE DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Systemic Lupus Erythematous SLE Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Systemic Lupus Erythematous SLE Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SYSTEMIC LUPUS ERYTHEMATOUS SLE DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Anthera Pharmaceuticals BMS
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.1.2.1 Corticosteroids
    6.1.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.1.3 Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.2.2.1 Corticosteroids
    6.2.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.2.3 GSK Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 ImmuPharma
  6.3.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.3.2.1 Corticosteroids
    6.3.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.3.3 ImmuPharma Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck Serono
  6.4.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.4.2.1 Corticosteroids
    6.4.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.4.3 Merck Serono Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 UCB
  6.5.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.5.2.1 Corticosteroids
    6.5.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.5.3 UCB Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Amgen
  6.6.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.6.2.1 Corticosteroids
    6.6.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.6.3 Amgen Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 HGS
  6.7.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.7.2.1 Corticosteroids
    6.7.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.7.3 HGS Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Immunomedics
  6.8.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.8.2.1 Corticosteroids
    6.8.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.8.3 Immunomedics Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 MedImmune
  6.9.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.9.2.1 Corticosteroids
    6.9.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.9.3 MedImmune Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sanofi
  6.10.2 Systemic Lupus Erythematous SLE Drugs Product Type, Application and Specification
    6.10.2.1 Corticosteroids
    6.10.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  6.10.3 Sanofi Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 SYSTEMIC LUPUS ERYTHEMATOUS SLE DRUGS MANUFACTURING COST ANALYSIS

7.1 Systemic Lupus Erythematous SLE Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Systemic Lupus Erythematous SLE Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Systemic Lupus Erythematous SLE Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Systemic Lupus Erythematous SLE Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SYSTEMIC LUPUS ERYTHEMATOUS SLE DRUGS MARKET FORECAST (2017-2022)

11.1 United States Systemic Lupus Erythematous SLE Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Systemic Lupus Erythematous SLE Drugs Sales Forecast by Type (2017-2022)
11.3 United States Systemic Lupus Erythematous SLE Drugs Sales Forecast by Application (2017-2022)
11.4 Systemic Lupus Erythematous SLE Drugs Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Systemic Lupus Erythematous SLE Drugs
Table Classification of Systemic Lupus Erythematous SLE Drugs
Figure United States Sales Market Share of Systemic Lupus Erythematous SLE Drugs by Type in 2015
Figure Corticosteroids Picture
Figure Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Picture
Figure Anti-Inflammatories Picture
Figure Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Picture
Figure Antimalarials Picture
Figure BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) Picture
Figure Immunosuppressive Agents/Immune Modulators Picture
Figure Anticoagulants Picture
Table Application of Systemic Lupus Erythematous SLE Drugs
Figure United States Sales Market Share of Systemic Lupus Erythematous SLE Drugs by Application in 2015
Figure Hospitals Examples
Figure Hospital Pharmacies Examples
Figure Drug Stores Examples
Figure Online Drug Stores Examples
Figure United States Systemic Lupus Erythematous SLE Drugs Sales and Growth Rate (2012-2022)
Figure United States Systemic Lupus Erythematous SLE Drugs Revenue and Growth Rate (2012-2022)
Table United States Systemic Lupus Erythematous SLE Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Systemic Lupus Erythematous SLE Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Systemic Lupus Erythematous SLE Drugs Sales Share by Manufacturers
Figure 2016 Systemic Lupus Erythematous SLE Drugs Sales Share by Manufacturers
Table United States Systemic Lupus Erythematous SLE Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Systemic Lupus Erythematous SLE Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Systemic Lupus Erythematous SLE Drugs Revenue Share by Manufacturers
Table 2016 United States Systemic Lupus Erythematous SLE Drugs Revenue Share by Manufacturers
Table United States Market Systemic Lupus Erythematous SLE Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Systemic Lupus Erythematous SLE Drugs Average Price of Key Manufacturers in 2015
Figure Systemic Lupus Erythematous SLE Drugs Market Share of Top 3 Manufacturers
Figure Systemic Lupus Erythematous SLE Drugs Market Share of Top 5 Manufacturers
Table United States Systemic Lupus Erythematous SLE Drugs Sales by States (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Sales Share by States (2012-2017)
Figure United States Systemic Lupus Erythematous SLE Drugs Sales Market Share by States in 2015
Table United States Systemic Lupus Erythematous SLE Drugs Revenue and Market Share by States (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Systemic Lupus Erythematous SLE Drugs by States (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Price by States (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Sales by Type (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Sales Share by Type (2012-2017)
Figure United States Systemic Lupus Erythematous SLE Drugs Sales Market Share by Type in 2015
Table United States Systemic Lupus Erythematous SLE Drugs Revenue and Market Share by Type (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Systemic Lupus Erythematous SLE Drugs by Type (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Price by Type (2012-2017)
Figure United States Systemic Lupus Erythematous SLE Drugs Sales Growth Rate by Type (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Sales by Application (2012-2017)
Table United States Systemic Lupus Erythematous SLE Drugs Sales Market Share by Application (2012-2017)
Figure United States Systemic Lupus Erythematous SLE Drugs Sales Market Share by Application in 2015
Table United States Systemic Lupus Erythematous SLE Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Systemic Lupus Erythematous SLE Drugs Sales Growth Rate by Application (2012-2017)
Table Anthera Pharmaceuticals BMS Basic Information List
Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table ImmuPharma Basic Information List
Table ImmuPharma Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table ImmuPharma Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Serono Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table UCB Basic Information List
Table UCB Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table UCB Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table HGS Basic Information List
Table HGS Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table HGS Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table Immunomedics Basic Information List
Table Immunomedics Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Systemic Lupus Erythematous SLE Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Systemic Lupus Erythematous SLE Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Systemic Lupus Erythematous SLE Drugs
Figure Manufacturing Process Analysis of Systemic Lupus Erythematous SLE Drugs
Figure Systemic Lupus Erythematous SLE Drugs Industrial Chain Analysis
Table Raw Materials Sources of Systemic Lupus Erythematous SLE Drugs Major Manufacturers in 2015
Table Major Buyers of Systemic Lupus Erythematous SLE Drugs
Table Distributors/Traders List
Figure United States Systemic Lupus Erythematous SLE Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Systemic Lupus Erythematous SLE Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Systemic Lupus Erythematous SLE Drugs Production Forecast by Type (2017-2022)
Table United States Systemic Lupus Erythematous SLE Drugs Consumption Forecast by Application (2017-2022)
Table United States Systemic Lupus Erythematous SLE Drugs Sales Forecast by States (2017-2022)
Table United States Systemic Lupus Erythematous SLE Drugs Sales Share Forecast by States (2017-2022)